Skip to main content
. Author manuscript; available in PMC: 2013 Jun 12.
Published in final edited form as: J Mol Cell Cardiol. 2011 Nov 19;52(1):228–236. doi: 10.1016/j.yjmcc.2011.11.005

Figure 6.

Figure 6

Nuclear contents of pTyr-STAT1 (A), pTyr-STAT3 (B), and pSer-STAT3 (C) at 30 min after administration of iCORM-3 (group VII) and CORM-3 (group VIII). Upper panels: Representative Western immunoblots showing increased nuclear levels of pTyr(701)-STAT1 (A), pTyr(705)-STAT3 (B), and pSer(727)-STAT3 (C) in myocardial samples from CORM-3-treated mice compared with iCORM-3-treated mice. Lower panels: Densitometric analysis of pTyr(701)-STAT1 (A), pTyr(705)-STAT3 (B), and pSer(727)-STAT3 (C) signals. Data are means±SEM. *P<0.05 vs. iCORM-3.